4//SEC Filing
Feltquate David 4
Accession 0000950170-24-090317
CIK 0001808865other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:19 AM ET
Size
5.5 KB
Accession
0000950170-24-090317
Insider Transaction Report
Form 4
Feltquate David
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-01+350,000→ 350,000 totalExercise: $17.46From: 2025-08-01Exp: 2034-08-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This stock option will vest over 4 years, with 25% of the stock option vesting on August 1, 2025, and thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0002031518
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 7:19 AM ET
- Size
- 5.5 KB